MGC Pharmaceuticals Ltd (LON:MXC) shares began Tuesday's session in London higher, after announcing a A$1mln wholesale order from Swiss firm PharmaCan for MGC's proprietary ArtemiC Rescue supplement which is being used by COVID-19 patients to support recovery. Changing hands at 3.52p in London, the share is up around 3
Full Story >>
Vote
+30